Han-Kyong Kim

Title: Han-Kyong Kim: Innovator in Pharmaceutical Composition

Introduction

Han-Kyong Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating obesity. His innovative work has led to the creation of a unique pharmaceutical composition that enhances the effectiveness of treatment options available for this condition.

Latest Patents

Han-Kyong Kim holds 1 patent for his invention titled "Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate." This invention relates to a pharmaceutical composition designed for treating or preventing obesity. The composition features a novel crystalline form of sibutramine methanesulfonate hemihydrate, which exhibits significantly higher solubility in water and improved stability under high humidity and temperature conditions compared to traditional sibutramine hydrochloride monohydrate.

Career Highlights

Kim is associated with Hanmi Pharm. Co., Ltd., a prominent company in the pharmaceutical industry. His work at Hanmi Pharm has allowed him to focus on innovative solutions that address pressing health issues, particularly obesity. His research and development efforts have positioned him as a key player in the pharmaceutical sector.

Collaborations

Throughout his career, Han-Kyong Kim has collaborated with esteemed colleagues, including Jae-Heon Lee and Gha-Seung Park. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Han-Kyong Kim's contributions to the field of pharmaceuticals, particularly through his patented invention, highlight his commitment to improving health outcomes. His innovative approach to treating obesity showcases the potential for advancements in medical treatments.